Aloe-emodin relieves zidovudine-induced injury in neonatal rat ventricular myocytes by regulating the p90rsk/p-bad/bcl-2 signaling pathway

Wei Zhao,Ye Yuan,Burong Feng,Yue Sun,Huiwei Jiang,Wei Zhao,Yuyang Zheng,Lihui Zhao,Tingting Chen,Yan Bai,Pengzhou Hang,Yingfu Chen,Zhimin Du
DOI: https://doi.org/10.1016/j.etap.2020.103540
IF: 4.3
2021-01-01
Environmental Toxicology and Pharmacology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background/Aims</h3><p>Zidovudine (3'-azido-2',3'-deoxythymidine; AZT) is a first-line drug for treatment of human immunodeficiency virus infection (HIV). However, its application is limited by cardiotoxicity due to cardiomyocyte injury. This study investigated whether Aloe-emodin (AE), an anthraquinone compound, protects against AZT-induced cardiomyocyte toxicity.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>MTT, JC-1 assays and TUNEL were examined to verify the protective effect of AE against AZT-induced cardiomyocyte injury. Western blotting was performed to explore the anti-apoptotic effect of AE using anti-apoptotic proteins p90rsk, <em>p</em>-bad, and bcl-2 and pro-apoptotic proteins apaf-1, cleaved-caspase-3, and cytochrome c.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>We observed a protective effect of AE against cell viability decrease and TUNEL positive cells increase induced by AZT, which was counteracted by BI-D1870. Western blot analysis found that AE significantly inhibited cardiomyocyte apoptosis by activating p90rsk/<em>p</em>-bad/bcl-2 signaling pathway. Furthermore, BI-D1870 counteracted the anti-apoptotic effect of AE.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Taken together, these results indicate that AE attenuated AZT-induced cardiomyocyte apoptosis by activating p90rsk.</p>
environmental sciences,toxicology,pharmacology & pharmacy
What problem does this paper attempt to address?